公司資料
Sonoma Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- SNOA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.34 USD (0.00%)
收盤價
最後更新: 2026年8月21日
4.03M USD
市值
股價為何變動
As of Aug 21, 2026, SNOA was little changed and closed at $1.34. No new same-company headline was identified in the current news window.
公司概覽
Hypochlorous Acid Medical Products
Sonoma Pharmaceuticals develops and manufactures stabilized hypochlorous acid products for wound care, eye care, nasal care, oral care, dermatology, podiatry, animal health, and non-toxic disinfection.
Microcyn Technology
The company’s Microcyn technology produces safe and stable HOCl formulations. The products are intended to reduce itching, pain, scarring, and irritation without damaging healthy tissue and are used in applications including minor abrasions, cuts, and intact-skin management.
Broad End-Market Portfolio
Sonoma adapts the same stabilized HOCl technology across human and animal healthcare. This creates a product portfolio serving wound care, dermatology, eye and nasal care, oral care, podiatry, animal health, and non-toxic disinfection.
Global Commercial Network
Sonoma products are sold directly or through partners in more than 55 countries. The company has recently expanded its U.S. product lineup and channel relationships, including the manufacture of a new HOCl wound cleanser for Medline.
未來催化劑
- Sonoma’s catalysts are wound-care and skin-health product demand, along with any update that clarifies the commercial path. The business moves on product adoption.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。